Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OsteoSight™ Hip (v1)

K-Number: K251408 · 2025-09-02

Decision Date2025-09-02
Product CodeSAO
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

OsteoSight™ Hip (v1) is a medical device manufactured by Naitive Technologies, Ltd.. It received FDA 510(k) clearance on 2025-09-02 under approval number K251408. The device is classified under product code SAO. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OsteoSight™ Hip (v1)?

OsteoSight™ Hip (v1) is a medical device that received FDA 510(k) clearance on 2025-09-02. It is manufactured by Naitive Technologies, Ltd.. The 510(k) number is K251408.

When was OsteoSight™ Hip (v1) approved by the FDA?

OsteoSight™ Hip (v1) received FDA 510(k) clearance on 2025-09-02, under approval number K251408.

What company makes OsteoSight™ Hip (v1)?

OsteoSight™ Hip (v1) is manufactured by Naitive Technologies, Ltd..

What is the FDA product code for OsteoSight™ Hip (v1)?

The FDA product code for OsteoSight™ Hip (v1) is SAO.

Related Devices (Code: SAO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.